InnovAge price to free cash flow INNV

Market value divided by free cash flow over the last twelve months, since 2022.

Today, Oct 23, 2026: 25.9×
5-year median: 31.8×
Against its 5-year history: 37th; percentile: 0 is its lowest day, 100 its highest
5-year range: 18.2× to 127×
Peer median: 14.7×

InnovAge's price to free cash flow is 25.9× as of Oct 23, 2026.

That is below its 5-year median of 31.8×, close to the middle of its last 5 years.

Over that time it ranged from 18.2× in Nov 2025 to 127× in Apr 2022.

The median for 10 hospital and care facility stocks of a similar size is 14.7×.

Price to free cash flow over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	25.9×	19.5×	38.2×
2025	20.8×	18.2×	37.7×
2024	n/m a value too high to mean anything
2023	n/m a value too high to mean anything
2022	51.7×	50.0×	127×

Against its peers

Companies in Medical - Care Facilities nearest InnovAge's size, closest first, today.

Company	Price to free cash flow
INNVInnovAge	25.9×
USPHU S Physical Therapy	20.6×
PNTGPennant	42.2×
OMDAOmada Health	51.0×
ARDTArdent Health	5.7×
HCSGHealthcare Services	11.7×
PGNYProgyny	12.5×
ADUSAddus HomeCare	14.7×
MDPediatrix Medical	10.4×
PRVAPrivia Health	n/m
AVAHAveanna Healthcare	18.4×
Peer median	14.7×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on InnovAge

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.